Profit taking weighs down Marinus Pharmaceuticals By: MarketMinute.com Stock News December 15, 2017 at 18:47 PM EST Investors locked in profits on Marinus Pharmaceuticals Inc. (Nasdaq: MRNS). Shares of the biopharmaceutical dropped $1.44 to close at $7.89. Related Stocks: Marinus Pharma CS
